Entero Therapeutics Common Stock

Entero Therapeutics (ENTO) currently reports a common stock of $610 as of March 2026. That compares with $480 in the prior-year period — up 28.1% year over year. Use the charts on this page to explore Entero Therapeutics's common stock history and peer comparisons.

Entero Therapeutics's common stock increased from $480 to $610 — a 28.1% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Entero Therapeutics reported $610 in common stock as of March 2026. That compares with $480 in the prior-year period — up 28.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $610, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Entero Therapeutics, and consider following ENTO for alerts when major investors trade the stock.